Browse by Author

Journal Article

Sasikumar, PG and Sudarshan, NS and Adurthi, S and Ramachandra, RK and Samiulla, DS and Lakshminarasimhan, A and Ramanathan, A and Chandrasekhar, T and Dhudashiya, AA and Talapati, SR and Gowda, N and Palakolanu, S and Mani, J and Srinivasrao, B and Joseph, D and Kumar, N and Nair, R and Atreya, HS and Gowda, N and Ramachandra, M (2021) PD-1 derived CA-170 is an oral immune checkpoint inhibitor that exhibits preclinical anti-tumor efficacy. In: Communications Biology, 4 (1).